Celltrion | 068270 - Cost Of Sales

Stock Price
220,000.00
Daily Change
2,500.00 1.15%
Monthly
4.27%
Yearly
22.49%
Q1 Forecast
202,377.00

Celltrion reported KRW402.86B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.47M 1.19M Jun/2025
Celltrion KRW 402.86B 14.24B Sep/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Moderna USD 207M 88M Sep/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 324.34M 3.38M Sep/2025
Viatris USD 2.39B 139.2M Sep/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025